Area of research
Public Health, Environmental and Occupational Health · Infectious Diseases
Research interest
Research interests include Mosquito-borne diseases and control, Viral Infections and Vectors, Blood Pressure and Hypertension Studies, and Malaria Research and Control.
<i>In silico</i> and <i>in vitro</i> evaluation of imatinib as an inhibitor for SARS-CoV-2.
SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe
Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles.
Estimated pulse wave velocity improves risk stratification for all-cause mortality in patients with COVID-19
Street RABV Induces the Cholinergic Anti-inflammatory Pathway in Human Monocyte-Derived Macrophages by Binding to nAChr α7.
The relationship between cardiac injury, inflammation and coagulation in predicting COVID-19 outcome.
Street RABV induces the cholinergic anti-inflammatory pathway in human monocyte-derived macrophages by binding to nAChr ɑ7, and upregulates the M2-c marker CD163
Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study.
Role of Low-Molecular-Weight Heparin in Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study.
Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV
Nanomedicine strategies to target coronavirus.
Particulate multivalent presentation of the receptor binding domain induces protective immune responses against MERS-CoV.
Dengue Fever and Severe Dengue in Barbados, 2008-2016.
Correction: <i>Zika Virus</i>-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of <i>Dengue Virus</i> Infection. <i>Vaccines</i> 2019, <i>7</i>, 72.
Bcr-Abl tyrosine kinase inhibitor imatinib as a potential drug for COVID-19
The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis.
<i>Zika Virus</i>-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of <i>Dengue Virus</i> Infection.
Zika Virus Infection Induces Elevation of Tissue Factor Production and Apoptosis on Human Umbilical Vein Endothelial Cells.
Combination therapy of rabies-infected mice with inhibitors of pro-inflammatory host response, antiviral compounds and human rabies immunoglobulin.
Combination drug treatment prolongs survival of experimentally infected mice with silver-haired bat rabies virus.
Inhibition of caspase-1 prolongs survival of mice infected with rabies virus.
Characterization of antibody response in patients with acute and chronic chikungunya virus disease.
Mannitol treatment is not effective in therapy of rabies virus infection in mice.
Cardiovascular risk stratification in primary care patients with arterial hypertension: Results from the Swiss Hypertension Cohort Study (HccH).
Zika Virus Outbreak on Curaçao and Bonaire, a Report Based on Laboratory Diagnostics Data.
Human to human transmission of arthropod-borne pathogens
Neurotropic virus infections as the cause of immediate and delayed neuropathology
The challenge of West Nile virus in Europe: knowledge gaps and research priorities
Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral
Can the quantity of cell‐free fetal DNA predict preeclampsia: a systematic review